Alterity Therapeutics Ratios (2009-2025) | ATHE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2016	Dec2016	Jun2017	Dec2017	Jun2018	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Profitability
EBT Margin (Quarter)		-95.29%		-308.48%		-73.95%		-218.14%
EBIT Margin (Quarter)		-95.29%		-308.48%		-73.95%		-218.14%
EBITDA Margin (Quarter)		-95.29%		-308.48%		-73.95%		-218.14%							0.00%		0.00%
Net Margin (Quarter)		-95.29%		-308.48%		-73.95%		-218.14%		0.86%
FCF Margin (Quarter)		-15.62%		-99.72%		-99.95%		-99.71%
Efficiency
Assets Average (Quarter)	12.61B	12.60B	9.51B	9.50B	0.02B	5.08B	5.08B	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.03B	0.02B	0.02B	0.01B	0.01B	0.02B	0.03B
Equity Average (Quarter)		0.07B	0.06B	0.06B	0.06B	0.01B	0.01B			0.74B	0.75B			0.81B	0.80B	0.92B	0.84B	1.67B	1.67B	3.50B
Invested Capital (Quarter)	0.02B	0.11B	0.02B	0.11B	0.01B	0.00B	0.01B		0.00B	1.48B	0.02B		0.02B	1.59B	0.01B	1.82B	-0.14B	3.48B	-0.15B	7.14B
Asset Utilization Ratio (Quarter)		0.01		0.00		0.00		0.90		42.93		0.44		0.66	0.00B	0.97	340.75B	1.83		0.55
Leverage & Solvency
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.00	4.82	0.00	6.56	0.86	0.00	0.83		0.72	54.29	0.91		0.86	72.38	0.84	126.27	-11.14	504.44	-4.91	191.07
Valuation
Enterprise Value (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.03B	-0.02B	-0.03B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.00B	-0.02B	-0.03B
Return Ratios
Return on Sales (Quarter)		-0.01%		-0.03%		-0.01%		-0.02%		0.00%
Return on Capital Employed (Quarter)								-136.03%
Return on Assets (Quarter)		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%	0.00%
Return on Equity (Quarter)		0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%			0.00%	0.00%

Research Tools

Developers

Alterity Therapeutics Ratios (2009-2025) | ATHE

Research Tools

Developers

Alterity Therapeutics Ratios (2009-2025) | ATHE

Create an account

Sign In

Reset Password